TY - JOUR
T1 - An Improvement of Survival Stratification in Glioblastoma Patients via Combining Subregional Radiomics Signatures
AU - Yang, Yang
AU - Han, Yu
AU - Hu, Xintao
AU - Wang, Wen
AU - Cui, Guangbin
AU - Guo, Lei
AU - Zhang, Xin
N1 - Publisher Copyright:
© Copyright © 2021 Yang, Han, Hu, Wang, Cui, Guo and Zhang.
PY - 2021/5/13
Y1 - 2021/5/13
N2 - Purpose: To investigate whether combining multiple radiomics signatures derived from the subregions of glioblastoma (GBM) can improve survival prediction of patients with GBM. Methods: In total, 129 patients were included in this study and split into training (n = 99) and test (n = 30) cohorts. Radiomics features were extracted from each tumor region then radiomics scores were obtained separately using least absolute shrinkage and selection operator (LASSO) COX regression. A clinical nomogram was also constructed using various clinical risk factors. Radiomics nomograms were constructed by combing a single radiomics signature from the whole tumor region with clinical risk factors or combining three radiomics signatures from three tumor subregions with clinical risk factors. The performance of these models was assessed by the discrimination, calibration and clinical usefulness metrics, and was compared with that of the clinical nomogram. Results: Incorporating the three radiomics signatures, i.e., Radscores for ET, NET, and ED, into the radiomics-based nomogram improved the performance in estimating survival (C-index: training/test cohort: 0.717/0.655) compared with that of the clinical nomogram (C-index: training/test cohort: 0.633/0.560) and that of the radiomics nomogram based on single region radiomics signatures (C-index: training/test cohort: 0.656/0.535). Conclusion: The multiregional radiomics nomogram exhibited a favorable survival stratification accuracy.
AB - Purpose: To investigate whether combining multiple radiomics signatures derived from the subregions of glioblastoma (GBM) can improve survival prediction of patients with GBM. Methods: In total, 129 patients were included in this study and split into training (n = 99) and test (n = 30) cohorts. Radiomics features were extracted from each tumor region then radiomics scores were obtained separately using least absolute shrinkage and selection operator (LASSO) COX regression. A clinical nomogram was also constructed using various clinical risk factors. Radiomics nomograms were constructed by combing a single radiomics signature from the whole tumor region with clinical risk factors or combining three radiomics signatures from three tumor subregions with clinical risk factors. The performance of these models was assessed by the discrimination, calibration and clinical usefulness metrics, and was compared with that of the clinical nomogram. Results: Incorporating the three radiomics signatures, i.e., Radscores for ET, NET, and ED, into the radiomics-based nomogram improved the performance in estimating survival (C-index: training/test cohort: 0.717/0.655) compared with that of the clinical nomogram (C-index: training/test cohort: 0.633/0.560) and that of the radiomics nomogram based on single region radiomics signatures (C-index: training/test cohort: 0.656/0.535). Conclusion: The multiregional radiomics nomogram exhibited a favorable survival stratification accuracy.
KW - glioblastoma
KW - magnetic resonance imaging
KW - multiregional
KW - radiomics nomogram
KW - survival stratification
UR - http://www.scopus.com/inward/record.url?scp=85107188055&partnerID=8YFLogxK
U2 - 10.3389/fnins.2021.683452
DO - 10.3389/fnins.2021.683452
M3 - 文章
AN - SCOPUS:85107188055
SN - 1662-4548
VL - 15
JO - Frontiers in Neuroscience
JF - Frontiers in Neuroscience
M1 - 683452
ER -